Review



h9c2 cells  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Elabscience Biotechnology h9c2 cells
    KLB overexpression enhances the protective effects of FGF21 treatment on hypoxia-induced cardiomyocyte injury in vitro . (A) Viability of <t>H9C2</t> cells exposed to hypoxia (HX), FGF21 and KLB overexpression (n=5). (B) Representative images of DHE staining (scale bar, 100 μ m), and DHE intensity was quantified to reflect ROS levels. (C) Representative TUNEL staining images of KLB-overexpressing H9C2 cells exposed to hypoxia and treated with FGF21 (n=4; scale bar, 100 μ m). (D) LDH leak from KLB-overexpressing H9C2 cells exposed to hypoxia and treated with FGF21 (n=8). (E) JC-1 staining of H9C2 cells (scale bar, 50 μ m). Mitochondrial membrane potential was estimated by the ratio of JC-1 aggregates (red, healthy mitochondria) and JC-1 monomers (green, depolarized mitochondria, n=5). ** P<0.01 and *** P<0.001 vs. the control (Con) group; ## P<0.01 and ### P<0.001 vs. hypoxia (HX). KLB, β-klotho; FGF21, fibroblast growth factor 21; AMI, acute myocardial infarction; LDH, lactate dehydrogenase.
    H9c2 Cells, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+medium/H9c2(2-1)+Cell+Complete+Medium/pmc11090263-84-5-26
    Average 93 stars, based on 23 article reviews
    h9c2 cells - by Bioz Stars, 2026-11
    93/100 stars

    Images

    1) Product Images from "Ultrasound-targeted microbubble destruction technology delivering β-klotho to the heart enhances FGF21 sensitivity and attenuates heart remodeling post-myocardial infarction"

    Article Title: Ultrasound-targeted microbubble destruction technology delivering β-klotho to the heart enhances FGF21 sensitivity and attenuates heart remodeling post-myocardial infarction

    Journal: International Journal of Molecular Medicine

    doi: 10.3892/ijmm.2024.5378

    KLB overexpression enhances the protective effects of FGF21 treatment on hypoxia-induced cardiomyocyte injury in vitro . (A) Viability of H9C2 cells exposed to hypoxia (HX), FGF21 and KLB overexpression (n=5). (B) Representative images of DHE staining (scale bar, 100 μ m), and DHE intensity was quantified to reflect ROS levels. (C) Representative TUNEL staining images of KLB-overexpressing H9C2 cells exposed to hypoxia and treated with FGF21 (n=4; scale bar, 100 μ m). (D) LDH leak from KLB-overexpressing H9C2 cells exposed to hypoxia and treated with FGF21 (n=8). (E) JC-1 staining of H9C2 cells (scale bar, 50 μ m). Mitochondrial membrane potential was estimated by the ratio of JC-1 aggregates (red, healthy mitochondria) and JC-1 monomers (green, depolarized mitochondria, n=5). ** P<0.01 and *** P<0.001 vs. the control (Con) group; ## P<0.01 and ### P<0.001 vs. hypoxia (HX). KLB, β-klotho; FGF21, fibroblast growth factor 21; AMI, acute myocardial infarction; LDH, lactate dehydrogenase.
    Figure Legend Snippet: KLB overexpression enhances the protective effects of FGF21 treatment on hypoxia-induced cardiomyocyte injury in vitro . (A) Viability of H9C2 cells exposed to hypoxia (HX), FGF21 and KLB overexpression (n=5). (B) Representative images of DHE staining (scale bar, 100 μ m), and DHE intensity was quantified to reflect ROS levels. (C) Representative TUNEL staining images of KLB-overexpressing H9C2 cells exposed to hypoxia and treated with FGF21 (n=4; scale bar, 100 μ m). (D) LDH leak from KLB-overexpressing H9C2 cells exposed to hypoxia and treated with FGF21 (n=8). (E) JC-1 staining of H9C2 cells (scale bar, 50 μ m). Mitochondrial membrane potential was estimated by the ratio of JC-1 aggregates (red, healthy mitochondria) and JC-1 monomers (green, depolarized mitochondria, n=5). ** P<0.01 and *** P<0.001 vs. the control (Con) group; ## P<0.01 and ### P<0.001 vs. hypoxia (HX). KLB, β-klotho; FGF21, fibroblast growth factor 21; AMI, acute myocardial infarction; LDH, lactate dehydrogenase.

    Techniques Used: Over Expression, In Vitro, Staining, TUNEL Assay, Membrane, Control

    Cardiac delivery of KLB enhances the antioxidant effects of FGF21 in the heart following AMI. (A) Western analysis and quantification of Nrf2 and KEAP1 expression in H9C2 cells (n=4). (B) The protein expression of HO-1, NQO1, Gstp1 and GCLM was assessed using western blot analysis (n=4). (C) Representative images of echocardiography at 4 weeks following AMI surgery. (D and E) The LVEF and LVFS were calculated (n=5). (F and G) DHE staining of the heart section (scale bar, 50 μ m) and quantification (n=5). ** P<0.01 and *** P<0.001 vs. AMI; # P<0.05, ## P<0.01 and ### P<0.001 vs. the AMI + KLB@cMBs + FGF21 group; ns, not significant. AMI, acute myocardial infarction; KLB, β-klotho; FGF21, fibroblast growth factor 21; CMB, cationic microbubble; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; Nrf2, nuclear factor erythroid 2-related factor 2; KEAP1, kelch-like ECH-associated protein 1; HO-1, heme oxygenase 1; NQO1, NAD(P)H quinone dehydrogenase 1; Gstp1, glutathione S-transferase pi-1; GCLM, glutamate-cysteine ligase modifier subunit.
    Figure Legend Snippet: Cardiac delivery of KLB enhances the antioxidant effects of FGF21 in the heart following AMI. (A) Western analysis and quantification of Nrf2 and KEAP1 expression in H9C2 cells (n=4). (B) The protein expression of HO-1, NQO1, Gstp1 and GCLM was assessed using western blot analysis (n=4). (C) Representative images of echocardiography at 4 weeks following AMI surgery. (D and E) The LVEF and LVFS were calculated (n=5). (F and G) DHE staining of the heart section (scale bar, 50 μ m) and quantification (n=5). ** P<0.01 and *** P<0.001 vs. AMI; # P<0.05, ## P<0.01 and ### P<0.001 vs. the AMI + KLB@cMBs + FGF21 group; ns, not significant. AMI, acute myocardial infarction; KLB, β-klotho; FGF21, fibroblast growth factor 21; CMB, cationic microbubble; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; Nrf2, nuclear factor erythroid 2-related factor 2; KEAP1, kelch-like ECH-associated protein 1; HO-1, heme oxygenase 1; NQO1, NAD(P)H quinone dehydrogenase 1; Gstp1, glutathione S-transferase pi-1; GCLM, glutamate-cysteine ligase modifier subunit.

    Techniques Used: Western Blot, Expressing, Staining

    Mitochondrial quality in the heart is improved by the UTMD-mediated KLB delivery and FGF21 treatment in rats post-infarction. (A) JC-1 staining of heart section post-infarction (scale bar, 100 μ m). (B) The ratio of JC-1 aggregates (red) and monomers (green) was used to assess mitochondrial membrane potential (n=5-6). (C) Mitochondrial OCR profile in H9C2 cells using an XF24 Extracellular Flux Analyzer. Oligomycin (1 μ mol/l), FCCP (4 μ mol/l) and rotenone (0.5 μ mol/l) plus antimycin A (0.5 μ mol/l) were added sequentially. (D) FCCP-related respiration, (E) basal respiration, (F) maximal respiration and (G) ATP turnover were calculated (n=4). *** P<0.001 vs. AMI; ## P<0.01 and ### P<0.001 vs. the AMI + KLB@CMBs + FGF21 group. CMB, cationic microbubble; UTMD, ultrasound-targeted microbubble destruction; KLB, β-klotho; FGF21, fibroblast growth factor 21; OCR, oxygen consumption rate; FCCP, carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone; AMI, acute myocardial infarction; HX, hypoxia.
    Figure Legend Snippet: Mitochondrial quality in the heart is improved by the UTMD-mediated KLB delivery and FGF21 treatment in rats post-infarction. (A) JC-1 staining of heart section post-infarction (scale bar, 100 μ m). (B) The ratio of JC-1 aggregates (red) and monomers (green) was used to assess mitochondrial membrane potential (n=5-6). (C) Mitochondrial OCR profile in H9C2 cells using an XF24 Extracellular Flux Analyzer. Oligomycin (1 μ mol/l), FCCP (4 μ mol/l) and rotenone (0.5 μ mol/l) plus antimycin A (0.5 μ mol/l) were added sequentially. (D) FCCP-related respiration, (E) basal respiration, (F) maximal respiration and (G) ATP turnover were calculated (n=4). *** P<0.001 vs. AMI; ## P<0.01 and ### P<0.001 vs. the AMI + KLB@CMBs + FGF21 group. CMB, cationic microbubble; UTMD, ultrasound-targeted microbubble destruction; KLB, β-klotho; FGF21, fibroblast growth factor 21; OCR, oxygen consumption rate; FCCP, carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone; AMI, acute myocardial infarction; HX, hypoxia.

    Techniques Used: Staining, Membrane

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Trillin protects against doxorubicin-induced cardiotoxicity through regulating Nrf2/HO-1 signaling pathway.
    Article Snippet: .. The levels of LDH and cardiac troponin T (cTnT) in H9c2 cells were determined using a biochemical kit and Elisa kit (Elabscience, Wuhan, China), respectively. .. The levels of CAT, GSH, SOD, and MDA in cardiac tissue and H9c2 cells were determined using a biochemical kit (Elabscience, Wuhan, China).

    Article Title: Trillin protects against doxorubicin-induced cardiotoxicity through regulating Nrf2/HO-1 signaling pathway
    Article Snippet: .. The levels of LDH and cardiac troponin T (cTnT) in H9c2 cells were determined using a biochemical kit and Elisa kit (Elabscience, Wuhan, China), respectively. .. The levels of CAT, GSH, SOD, and MDA in cardiac tissue and H9c2 cells were determined using a biochemical kit (Elabscience, Wuhan, China).

    Article Title: Dipyridamole Acts as Clinical Ferroptosis Inhibitor to Prevent from Tissue Injury
    Article Snippet: The primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd. .. H9c2 cells were exposed to RSL3, Fer‐1 (4 μ m ) or dipyridamole (10 μ m ) for 6 h. 1 × 10 6 cells per sample were collected and intracellular CK‐MB or BNP levels were determined using the Rat CK‐MB (Creatine Kinase MB Isoenzyme) ELISA Kit (Elabscience, E‐EL‐R1327) and Rat BNP (Brain Natriuretic Peptide) ELISA Kit (E‐EL‐R0126) according to the manufacturer's instructions. .. HT1080 cells were exposed to RSL3 (250 n m ), Fer‐1 (4 μ m ), or dipyridamole (10 μ m ) for 8 h. 3 × 10 5 cells per sample were collected, and intracellular GSH levels were determined using the GSSG/GSH Quantification Kit II (DOJINDO, G263) according to the manufacturer's instructions.

    Multiple Displacement Amplification:

    Article Title: Trillin protects against doxorubicin-induced cardiotoxicity through regulating Nrf2/HO-1 signaling pathway.
    Article Snippet: The levels of LDH and cardiac troponin T (cTnT) in H9c2 cells were determined using a biochemical kit and Elisa kit (Elabscience, Wuhan, China), respectively. .. The levels of CAT, GSH, SOD, and MDA in cardiac tissue and H9c2 cells were determined using a biochemical kit (Elabscience, Wuhan, China). ..

    Article Title: LncRNA AK020546 Alleviates Myocardial Ischemia-Reperfusion Injury via Suppressing METTL14/m6A/MST1 Axis-Mediated Ferroptosis.
    Article Snippet: Ferroptosis occurs after myocardial ischemia–reperfusion (I/R) injury.. Long non-coding RNA (lncRNA) AK020546 possesses the effect of protecting the myocardium from I/R injury; however, the underlying mechanisms remain not fully understood.. This study aimed to investigate the effect of AK020546 on ferroptosis in cardiomyocytes and underlying molecular mechanisms.

    Article Title: Trillin protects against doxorubicin-induced cardiotoxicity through regulating Nrf2/HO-1 signaling pathway
    Article Snippet: The levels of LDH and cardiac troponin T (cTnT) in H9c2 cells were determined using a biochemical kit and Elisa kit (Elabscience, Wuhan, China), respectively. .. The levels of CAT, GSH, SOD, and MDA in cardiac tissue and H9c2 cells were determined using a biochemical kit (Elabscience, Wuhan, China). ..

    Article Title: Active and passive targeted delivery of anti-ferroptotic therapy for post-resuscitation myocardial dysfunction
    Article Snippet: Finally, enzymatic activity was estimated by measuring the absorbance of the sample at 450 nm using a plate reader (Flexstation 3; Molecular Devices). .. MDA and SOD levels in H9c2 cells and cardiac tissues, as well as H 2 O 2 levels in cardiac tissues were determined using colorimetric assay kits according to the manufacturer’s protocols (MDA: Cat#10009055; SOD: Cat#706002; Cayman, Ann Arbo, MI, USA; H 2 O 2 : E-BC-K102-M; Elabscience, Wuhan, China). ..

    Peptide ELISA:

    Article Title: Dipyridamole Acts as Clinical Ferroptosis Inhibitor to Prevent from Tissue Injury
    Article Snippet: The primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd. .. H9c2 cells were exposed to RSL3, Fer‐1 (4 μ m ) or dipyridamole (10 μ m ) for 6 h. 1 × 10 6 cells per sample were collected and intracellular CK‐MB or BNP levels were determined using the Rat CK‐MB (Creatine Kinase MB Isoenzyme) ELISA Kit (Elabscience, E‐EL‐R1327) and Rat BNP (Brain Natriuretic Peptide) ELISA Kit (E‐EL‐R0126) according to the manufacturer's instructions. .. HT1080 cells were exposed to RSL3 (250 n m ), Fer‐1 (4 μ m ), or dipyridamole (10 μ m ) for 8 h. 3 × 10 5 cells per sample were collected, and intracellular GSH levels were determined using the GSSG/GSH Quantification Kit II (DOJINDO, G263) according to the manufacturer's instructions.

    Colorimetric Assay:

    Article Title: LncRNA AK020546 Alleviates Myocardial Ischemia-Reperfusion Injury via Suppressing METTL14/m6A/MST1 Axis-Mediated Ferroptosis.
    Article Snippet: Ferroptosis occurs after myocardial ischemia–reperfusion (I/R) injury.. Long non-coding RNA (lncRNA) AK020546 possesses the effect of protecting the myocardium from I/R injury; however, the underlying mechanisms remain not fully understood.. This study aimed to investigate the effect of AK020546 on ferroptosis in cardiomyocytes and underlying molecular mechanisms.

    Article Title: Active and passive targeted delivery of anti-ferroptotic therapy for post-resuscitation myocardial dysfunction
    Article Snippet: Finally, enzymatic activity was estimated by measuring the absorbance of the sample at 450 nm using a plate reader (Flexstation 3; Molecular Devices). .. MDA and SOD levels in H9c2 cells and cardiac tissues, as well as H 2 O 2 levels in cardiac tissues were determined using colorimetric assay kits according to the manufacturer’s protocols (MDA: Cat#10009055; SOD: Cat#706002; Cayman, Ann Arbo, MI, USA; H 2 O 2 : E-BC-K102-M; Elabscience, Wuhan, China). ..



    Similar Products

    96
    ATCC dermal cell basal medium
    Dermal Cell Basal Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+medium/Dermal+Cell+Basal+Medium/pmc13764182-143-10-15
    Average 96 stars, based on 1 article reviews
    dermal cell basal medium - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    PromoCell endothelial cell growth medium ecgm mv2
    Endothelial Cell Growth Medium Ecgm Mv2, supplied by PromoCell, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+medium/Endothelial+Cell+Growth+Medium/pmc13756975-107-5-10
    Average 98 stars, based on 1 article reviews
    endothelial cell growth medium ecgm mv2 - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    99
    MedChemExpress medium
    Truncated APC regulates CRC apoptosis by modulating ARHGEF11 alternative splicing. ( A ) <t>CCK-8</t> assay showing proliferation of SW480 and HT29 cells following Trunc-APC or ARHGEF11-L knockdown compared to controls. ( B ) Colony formation assay of SW480 and HT29 cells with Trunc-APC or ARHGEF11-L knockdown versus controls. ( C ) CCK-8 assay assessing proliferation of SW480 and HT29 cells upon ARHGEF11-L reintroduction following Trunc-APC knockdown compared to controls. ( D ) Colony formation assay of SW480 and HT29 cells with or without ARHGEF11-L reintroduction following Trunc-APC knockdown. ( E ) Gross images and tumor weights of xenografts derived from the indicated cell lines in nude mice. ( F ) Immunohistochemical staining and quantitative analysis of Ki67 expression in xenograft tumors (scale bar = 50 μm). ( G ) Waterfall plot of ΔPSI values for ARHGEF11 splicing across 22 paired CRC tissue samples. ( H ) Representative flow cytometry plots and quantification of apoptotic cells in SW480 cells following ARHGEF11-L knockdown, Trunc-APC knockdown, ARHGEF11-L reintroduction, or control treatment. ( I ) IP assay showing BAX–Bcl-xL interactions in SW480 cells under the same conditions as in panel (H). Data are presented as mean ± SD [ n = 3 for panels (A)–(D) and (H); n = 6 for panels (E) and (F); biologically independent replicates]. Statistical analysis was performed using unpaired, two-tailed Student’s t-test (* P < .05, ** P < .01, *** P < .001, **** P < .0001).
    Medium, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+medium/Cell+Counting+Kit-8/pmc13752514-114-15-22
    Average 99 stars, based on 1 article reviews
    medium - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Beyotime culture medium
    Truncated APC regulates CRC apoptosis by modulating ARHGEF11 alternative splicing. ( A ) <t>CCK-8</t> assay showing proliferation of SW480 and HT29 cells following Trunc-APC or ARHGEF11-L knockdown compared to controls. ( B ) Colony formation assay of SW480 and HT29 cells with Trunc-APC or ARHGEF11-L knockdown versus controls. ( C ) CCK-8 assay assessing proliferation of SW480 and HT29 cells upon ARHGEF11-L reintroduction following Trunc-APC knockdown compared to controls. ( D ) Colony formation assay of SW480 and HT29 cells with or without ARHGEF11-L reintroduction following Trunc-APC knockdown. ( E ) Gross images and tumor weights of xenografts derived from the indicated cell lines in nude mice. ( F ) Immunohistochemical staining and quantitative analysis of Ki67 expression in xenograft tumors (scale bar = 50 μm). ( G ) Waterfall plot of ΔPSI values for ARHGEF11 splicing across 22 paired CRC tissue samples. ( H ) Representative flow cytometry plots and quantification of apoptotic cells in SW480 cells following ARHGEF11-L knockdown, Trunc-APC knockdown, ARHGEF11-L reintroduction, or control treatment. ( I ) IP assay showing BAX–Bcl-xL interactions in SW480 cells under the same conditions as in panel (H). Data are presented as mean ± SD [ n = 3 for panels (A)–(D) and (H); n = 6 for panels (E) and (F); biologically independent replicates]. Statistical analysis was performed using unpaired, two-tailed Student’s t-test (* P < .05, ** P < .01, *** P < .001, **** P < .0001).
    Culture Medium, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+medium/Cell+Culture+Freezing+Medium/pm42971006-296-4-43
    Average 99 stars, based on 1 article reviews
    culture medium - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    Sino Biological expi293f 293f cells
    Truncated APC regulates CRC apoptosis by modulating ARHGEF11 alternative splicing. ( A ) <t>CCK-8</t> assay showing proliferation of SW480 and HT29 cells following Trunc-APC or ARHGEF11-L knockdown compared to controls. ( B ) Colony formation assay of SW480 and HT29 cells with Trunc-APC or ARHGEF11-L knockdown versus controls. ( C ) CCK-8 assay assessing proliferation of SW480 and HT29 cells upon ARHGEF11-L reintroduction following Trunc-APC knockdown compared to controls. ( D ) Colony formation assay of SW480 and HT29 cells with or without ARHGEF11-L reintroduction following Trunc-APC knockdown. ( E ) Gross images and tumor weights of xenografts derived from the indicated cell lines in nude mice. ( F ) Immunohistochemical staining and quantitative analysis of Ki67 expression in xenograft tumors (scale bar = 50 μm). ( G ) Waterfall plot of ΔPSI values for ARHGEF11 splicing across 22 paired CRC tissue samples. ( H ) Representative flow cytometry plots and quantification of apoptotic cells in SW480 cells following ARHGEF11-L knockdown, Trunc-APC knockdown, ARHGEF11-L reintroduction, or control treatment. ( I ) IP assay showing BAX–Bcl-xL interactions in SW480 cells under the same conditions as in panel (H). Data are presented as mean ± SD [ n = 3 for panels (A)–(D) and (H); n = 6 for panels (E) and (F); biologically independent replicates]. Statistical analysis was performed using unpaired, two-tailed Student’s t-test (* P < .05, ** P < .01, *** P < .001, **** P < .0001).
    Expi293f 293f Cells, supplied by Sino Biological, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+medium/SMM+293-TI+Expression+Medium/pmc13748770-255-0-10
    Average 96 stars, based on 1 article reviews
    expi293f 293f cells - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    Sino Biological plasmidwas transfected intohek293f cells
    Truncated APC regulates CRC apoptosis by modulating ARHGEF11 alternative splicing. ( A ) <t>CCK-8</t> assay showing proliferation of SW480 and HT29 cells following Trunc-APC or ARHGEF11-L knockdown compared to controls. ( B ) Colony formation assay of SW480 and HT29 cells with Trunc-APC or ARHGEF11-L knockdown versus controls. ( C ) CCK-8 assay assessing proliferation of SW480 and HT29 cells upon ARHGEF11-L reintroduction following Trunc-APC knockdown compared to controls. ( D ) Colony formation assay of SW480 and HT29 cells with or without ARHGEF11-L reintroduction following Trunc-APC knockdown. ( E ) Gross images and tumor weights of xenografts derived from the indicated cell lines in nude mice. ( F ) Immunohistochemical staining and quantitative analysis of Ki67 expression in xenograft tumors (scale bar = 50 μm). ( G ) Waterfall plot of ΔPSI values for ARHGEF11 splicing across 22 paired CRC tissue samples. ( H ) Representative flow cytometry plots and quantification of apoptotic cells in SW480 cells following ARHGEF11-L knockdown, Trunc-APC knockdown, ARHGEF11-L reintroduction, or control treatment. ( I ) IP assay showing BAX–Bcl-xL interactions in SW480 cells under the same conditions as in panel (H). Data are presented as mean ± SD [ n = 3 for panels (A)–(D) and (H); n = 6 for panels (E) and (F); biologically independent replicates]. Statistical analysis was performed using unpaired, two-tailed Student’s t-test (* P < .05, ** P < .01, *** P < .001, **** P < .0001).
    Plasmidwas Transfected Intohek293f Cells, supplied by Sino Biological, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+medium/SMM+293-TII+Expression+Medium/pm43000427-375-4-14
    Average 98 stars, based on 1 article reviews
    plasmidwas transfected intohek293f cells - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    96
    ATCC airway epithelial cell basal medium
    Truncated APC regulates CRC apoptosis by modulating ARHGEF11 alternative splicing. ( A ) <t>CCK-8</t> assay showing proliferation of SW480 and HT29 cells following Trunc-APC or ARHGEF11-L knockdown compared to controls. ( B ) Colony formation assay of SW480 and HT29 cells with Trunc-APC or ARHGEF11-L knockdown versus controls. ( C ) CCK-8 assay assessing proliferation of SW480 and HT29 cells upon ARHGEF11-L reintroduction following Trunc-APC knockdown compared to controls. ( D ) Colony formation assay of SW480 and HT29 cells with or without ARHGEF11-L reintroduction following Trunc-APC knockdown. ( E ) Gross images and tumor weights of xenografts derived from the indicated cell lines in nude mice. ( F ) Immunohistochemical staining and quantitative analysis of Ki67 expression in xenograft tumors (scale bar = 50 μm). ( G ) Waterfall plot of ΔPSI values for ARHGEF11 splicing across 22 paired CRC tissue samples. ( H ) Representative flow cytometry plots and quantification of apoptotic cells in SW480 cells following ARHGEF11-L knockdown, Trunc-APC knockdown, ARHGEF11-L reintroduction, or control treatment. ( I ) IP assay showing BAX–Bcl-xL interactions in SW480 cells under the same conditions as in panel (H). Data are presented as mean ± SD [ n = 3 for panels (A)–(D) and (H); n = 6 for panels (E) and (F); biologically independent replicates]. Statistical analysis was performed using unpaired, two-tailed Student’s t-test (* P < .05, ** P < .01, *** P < .001, **** P < .0001).
    Airway Epithelial Cell Basal Medium, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+medium/Airway+Epithelial+Cell+Basal+Medium/10__1096_slash_fj__202602933r-50-0-14
    Average 96 stars, based on 1 article reviews
    airway epithelial cell basal medium - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    PromoCell skeletal muscle growth medium
    Truncated APC regulates CRC apoptosis by modulating ARHGEF11 alternative splicing. ( A ) <t>CCK-8</t> assay showing proliferation of SW480 and HT29 cells following Trunc-APC or ARHGEF11-L knockdown compared to controls. ( B ) Colony formation assay of SW480 and HT29 cells with Trunc-APC or ARHGEF11-L knockdown versus controls. ( C ) CCK-8 assay assessing proliferation of SW480 and HT29 cells upon ARHGEF11-L reintroduction following Trunc-APC knockdown compared to controls. ( D ) Colony formation assay of SW480 and HT29 cells with or without ARHGEF11-L reintroduction following Trunc-APC knockdown. ( E ) Gross images and tumor weights of xenografts derived from the indicated cell lines in nude mice. ( F ) Immunohistochemical staining and quantitative analysis of Ki67 expression in xenograft tumors (scale bar = 50 μm). ( G ) Waterfall plot of ΔPSI values for ARHGEF11 splicing across 22 paired CRC tissue samples. ( H ) Representative flow cytometry plots and quantification of apoptotic cells in SW480 cells following ARHGEF11-L knockdown, Trunc-APC knockdown, ARHGEF11-L reintroduction, or control treatment. ( I ) IP assay showing BAX–Bcl-xL interactions in SW480 cells under the same conditions as in panel (H). Data are presented as mean ± SD [ n = 3 for panels (A)–(D) and (H); n = 6 for panels (E) and (F); biologically independent replicates]. Statistical analysis was performed using unpaired, two-tailed Student’s t-test (* P < .05, ** P < .01, *** P < .001, **** P < .0001).
    Skeletal Muscle Growth Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+medium/Skeletal+Muscle+Cell+Growth+Medium/bio_rxiv__64898__2026__11__05__764057-400-8-12
    Average 96 stars, based on 1 article reviews
    skeletal muscle growth medium - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Truncated APC regulates CRC apoptosis by modulating ARHGEF11 alternative splicing. ( A ) CCK-8 assay showing proliferation of SW480 and HT29 cells following Trunc-APC or ARHGEF11-L knockdown compared to controls. ( B ) Colony formation assay of SW480 and HT29 cells with Trunc-APC or ARHGEF11-L knockdown versus controls. ( C ) CCK-8 assay assessing proliferation of SW480 and HT29 cells upon ARHGEF11-L reintroduction following Trunc-APC knockdown compared to controls. ( D ) Colony formation assay of SW480 and HT29 cells with or without ARHGEF11-L reintroduction following Trunc-APC knockdown. ( E ) Gross images and tumor weights of xenografts derived from the indicated cell lines in nude mice. ( F ) Immunohistochemical staining and quantitative analysis of Ki67 expression in xenograft tumors (scale bar = 50 μm). ( G ) Waterfall plot of ΔPSI values for ARHGEF11 splicing across 22 paired CRC tissue samples. ( H ) Representative flow cytometry plots and quantification of apoptotic cells in SW480 cells following ARHGEF11-L knockdown, Trunc-APC knockdown, ARHGEF11-L reintroduction, or control treatment. ( I ) IP assay showing BAX–Bcl-xL interactions in SW480 cells under the same conditions as in panel (H). Data are presented as mean ± SD [ n = 3 for panels (A)–(D) and (H); n = 6 for panels (E) and (F); biologically independent replicates]. Statistical analysis was performed using unpaired, two-tailed Student’s t-test (* P < .05, ** P < .01, *** P < .001, **** P < .0001).

    Journal: Nucleic Acids Research

    Article Title: Truncated APC regulates alternative splicing by interacting with DDX21 in colorectal cancer

    doi: 10.1093/nar/gkag1153

    Figure Lengend Snippet: Truncated APC regulates CRC apoptosis by modulating ARHGEF11 alternative splicing. ( A ) CCK-8 assay showing proliferation of SW480 and HT29 cells following Trunc-APC or ARHGEF11-L knockdown compared to controls. ( B ) Colony formation assay of SW480 and HT29 cells with Trunc-APC or ARHGEF11-L knockdown versus controls. ( C ) CCK-8 assay assessing proliferation of SW480 and HT29 cells upon ARHGEF11-L reintroduction following Trunc-APC knockdown compared to controls. ( D ) Colony formation assay of SW480 and HT29 cells with or without ARHGEF11-L reintroduction following Trunc-APC knockdown. ( E ) Gross images and tumor weights of xenografts derived from the indicated cell lines in nude mice. ( F ) Immunohistochemical staining and quantitative analysis of Ki67 expression in xenograft tumors (scale bar = 50 μm). ( G ) Waterfall plot of ΔPSI values for ARHGEF11 splicing across 22 paired CRC tissue samples. ( H ) Representative flow cytometry plots and quantification of apoptotic cells in SW480 cells following ARHGEF11-L knockdown, Trunc-APC knockdown, ARHGEF11-L reintroduction, or control treatment. ( I ) IP assay showing BAX–Bcl-xL interactions in SW480 cells under the same conditions as in panel (H). Data are presented as mean ± SD [ n = 3 for panels (A)–(D) and (H); n = 6 for panels (E) and (F); biologically independent replicates]. Statistical analysis was performed using unpaired, two-tailed Student’s t-test (* P < .05, ** P < .01, *** P < .001, **** P < .0001).

    Article Snippet: Cell proliferation was assessed by adding 100 μl of a mixture containing 90 μl serum-free medium and 10 μl CCK-8 solution (HY-K0301, MedChemExpress) to each well.

    Techniques: Alternative Splicing, CCK-8 Assay, Knockdown, Colony Assay, Derivative Assay, Immunohistochemical staining, Staining, Analysis, Expressing, Xenograft Assay, Tissue, Flow Cytometry, Control, Two Tailed Test, Immunohistochemistry

    Splicing modulation suppresses colorectal tumorigenesis in Apc Min/+ mice. ( A ) CCK-8 assay showing relative viability of indicated CRC cell lines treated with various concentrations of splicing inhibitors for 48 h. ( B ) Semi-quantitative RT-PCR analysis of alternative splicing changes in indicated genes in SW480 cells treated with splicing inhibitors for 36 h at the indicated concentrations. ( C ) Schematic illustration of treatment regimens for different Apc Min/+ mouse groups. ( D ) Representative H&E-stained sections of colorectal tumors from Apc Min/+ mice treated with vehicle or Madrasin (scale bar = 5 mm); arrows indicate tumor locations. ( E ) Effect of Madrasin treatment on colorectal tumor number and volume in Apc Min/+ mice. ( F ) Representative IHC staining and quantification of Ki67 expression in intestinal tissues of Apc Min/+ mice treated with vehicle or Madrasin (scale bar = 50 μm). ( G ) Body weight changes in Apc Min/+ mice treated with vehicle or Madrasin. Data in panels (E)–(G) are presented as mean ± SD ( n = 6 biologically independent mice). Statistical analysis was performed using an unpaired, two-tailed Student’s t-test (* P < .05, ** P < .01, *** P < .001, **** P < .0001). ( H ) Representative H&E staining of major organs from Apc Min/+ mice treated with vehicle or Madrasin (scale bar = 50 μm).

    Journal: Nucleic Acids Research

    Article Title: Truncated APC regulates alternative splicing by interacting with DDX21 in colorectal cancer

    doi: 10.1093/nar/gkag1153

    Figure Lengend Snippet: Splicing modulation suppresses colorectal tumorigenesis in Apc Min/+ mice. ( A ) CCK-8 assay showing relative viability of indicated CRC cell lines treated with various concentrations of splicing inhibitors for 48 h. ( B ) Semi-quantitative RT-PCR analysis of alternative splicing changes in indicated genes in SW480 cells treated with splicing inhibitors for 36 h at the indicated concentrations. ( C ) Schematic illustration of treatment regimens for different Apc Min/+ mouse groups. ( D ) Representative H&E-stained sections of colorectal tumors from Apc Min/+ mice treated with vehicle or Madrasin (scale bar = 5 mm); arrows indicate tumor locations. ( E ) Effect of Madrasin treatment on colorectal tumor number and volume in Apc Min/+ mice. ( F ) Representative IHC staining and quantification of Ki67 expression in intestinal tissues of Apc Min/+ mice treated with vehicle or Madrasin (scale bar = 50 μm). ( G ) Body weight changes in Apc Min/+ mice treated with vehicle or Madrasin. Data in panels (E)–(G) are presented as mean ± SD ( n = 6 biologically independent mice). Statistical analysis was performed using an unpaired, two-tailed Student’s t-test (* P < .05, ** P < .01, *** P < .001, **** P < .0001). ( H ) Representative H&E staining of major organs from Apc Min/+ mice treated with vehicle or Madrasin (scale bar = 50 μm).

    Article Snippet: Cell proliferation was assessed by adding 100 μl of a mixture containing 90 μl serum-free medium and 10 μl CCK-8 solution (HY-K0301, MedChemExpress) to each well.

    Techniques: CCK-8 Assay, Quantitative RT-PCR, Analysis, Alternative Splicing, Staining, Immunohistochemistry, Expressing, Two Tailed Test